Marc Debled
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 56
- Cancer Treatment and Pharmacology 22
- HER2/EGFR in Cancer Research 16
- Cancer Diagnosis and Treatment 6
-
- Breast Cancer Treatment Studies 39
- Co-authors
- Gaëtan MacGrogan (29 shared papers)Véronique Brouste (23 shared papers)L. Mauriac (24 shared papers)Simone Mathoulin‐Pélissier (13 shared papers)C. Tunon de Lara (18 shared papers)Thomas Bachelot (15 shared papers)Carine Bellera (4 shared papers)M. Durand (9 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (11 papers)Cancer Research (7 papers)Breast Cancer Research and Treatment (6 papers)British Journal of Cancer (6 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Marc Debled
118 papers receiving 3.8k citations
Marc Debled's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.3k
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 803
- Family Practice 45
- Pathology and Forensic Medicine 379
Countries citing papers authored by Marc Debled
This map shows the geographic impact of Marc Debled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Debled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Debled more than expected).
Fields of papers citing papers by Marc Debled
This network shows the impact of papers produced by Marc Debled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Debled. The network helps show where Marc Debled may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Debled, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study Hit paper breakdown → | 2012 | 560 |
| 2 | 1999 | 365 | |
| 3 | 2010 | 297 | |
| 4 | 2012 | 247 | |
| 5 | 2013 | 232 | |
| 6 | 2016 | 171 | |
| 7 | 2011 | 129 | |
| 8 | 2015 | 126 | |
| 9 | 2007 | 107 | |
| 10 | 2017 | 101 | |
| 11 | 2017 | 87 | |
| 12 | 2015 | 70 | |
| 13 | 2013 | 64 | |
| 14 | 2017 | 59 | |
| 15 | 2012 | 54 | |
| 16 | 2018 | 53 | |
| 17 | 2012 | 50 | |
| 18 | 2012 | 49 | |
| 19 | 2013 | 46 | |
| 20 | 2010 | 46 |
About Marc Debled
Marc Debled is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 123 papers that have together received 4.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (39 papers), Advanced Breast Cancer Therapies (26 papers), Cancer Treatment and Pharmacology (22 papers), HER2/EGFR in Cancer Research (16 papers), Estrogen and related hormone effects (9 papers), Breast Lesions and Carcinomas (7 papers), Cancer Diagnosis and Treatment (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (803 citations), Family Practice (45 citations) and Pathology and Forensic Medicine (379 citations). Marc Debled has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Gaëtan MacGrogan, Véronique Brouste, L. Mauriac, Simone Mathoulin‐Pélissier, C. Tunon de Lara, Thomas Bachelot, Carine Bellera, M. Durand, Sophie Abadie‐Lacourtoisie and Anne Floquet. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Cancer Research and Treatment and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.